Your browser doesn't support javascript.
loading
Liquid Biopsies Using Plasma Exosomal Nucleic Acids and Plasma Cell-Free DNA Compared with Clinical Outcomes of Patients with Advanced Cancers.
Möhrmann, Lino; Huang, Helen J; Hong, David S; Tsimberidou, Apostolia M; Fu, Siqing; Piha-Paul, Sarina A; Subbiah, Vivek; Karp, Daniel D; Naing, Aung; Krug, Anne; Enderle, Daniel; Priewasser, Tina; Noerholm, Mikkel; Eitan, Erez; Coticchia, Christine; Stoll, Georg; Jordan, Lisa-Marie; Eng, Cathy; Kopetz, E Scott; Skog, Johan; Meric-Bernstam, Funda; Janku, Filip.
Afiliação
  • Möhrmann L; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Huang HJ; Department of Translational Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Hong DS; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Tsimberidou AM; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Fu S; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Piha-Paul SA; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Subbiah V; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Karp DD; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Naing A; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Krug A; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Enderle D; Exosome Diagnostics, Waltham, Massachusetts.
  • Priewasser T; Exosome Diagnostics, Waltham, Massachusetts.
  • Noerholm M; Exosome Diagnostics, Waltham, Massachusetts.
  • Eitan E; Exosome Diagnostics, Waltham, Massachusetts.
  • Coticchia C; Exosome Diagnostics, Waltham, Massachusetts.
  • Stoll G; Exosome Diagnostics, Waltham, Massachusetts.
  • Jordan LM; Exosome Diagnostics, Waltham, Massachusetts.
  • Eng C; Exosome Diagnostics, Waltham, Massachusetts.
  • Kopetz ES; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Skog J; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Meric-Bernstam F; Exosome Diagnostics, Waltham, Massachusetts.
  • Janku F; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.
Clin Cancer Res ; 24(1): 181-188, 2018 01 01.
Article em En | MEDLINE | ID: mdl-29051321
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Exossomos / Ácidos Nucleicos Livres / Biópsia Líquida / Neoplasias Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Exossomos / Ácidos Nucleicos Livres / Biópsia Líquida / Neoplasias Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Ano de publicação: 2018 Tipo de documento: Article